Moderna finalizes agreement to establish Kenya mRNA manufacturing facility

Moderna, a biotechnology company that produces mRNA vaccines, has announced that it has finalized an agreement with the government of Kenya to establish a manufacturing facility for mRNA vaccines in the country.

• The facility will be the first of its kind in Africa and will enable the production of up to 100 million doses of mRNA vaccines per year.
• The agreement includes a technology transfer from Moderna to Kenya, as well as training and development of local personnel.
• The facility is expected to create job opportunities and support the local economy in Kenya.
• Moderna has also pledged to donate an initial 1 million doses of its COVID-19 vaccine to Kenya.
• This move is part of Moderna’s larger efforts to increase global access to its mRNA vaccine technology.